Leucadia National Corporation »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 1.7M 0.97
2023-12-31 $9.4M 10M 0.93
2023-09-30 $4.0M 4.3M 0.94

More positions owned by Leucadia National Corporation

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Walt Disney Company (DIS)
Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Russell 2000 Etf (IWM)
Delta Air Lines Inc Del Com New (DAL)
Visa Com Cl A (V)
Uber Technologies (UBER)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Micron Technology (MU)
Spdr Ser Tr S&p Biotech (XBI)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Hillman Solutions Corp (HLMN)

View all positions for Leucadia National Corporation

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Polar Securities
CNH Partners
Millennium Management
Absolute Investment Advisers
Citadel Advisors
Kohlberg Kravis Roberts & Co
SSI Investment Management
Morgan Stanley
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Amundi

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1